Controlled drug release from bifunctionalized mesoporous silica

Serial of trimethylsilyl-carboxyl bifunctionalized SBA-15 (TMS/COOH/SBA-15) have been studied as carriers for controlled release of drug famotidine (Famo). To load Famo with large capacity, SBA-15 with high content of carboxyl groups was successfully synthesized by one-pot synthesis under the assistance of KCl. The mesostructure of carboxyl functionalized SBA-15 (COOH/SBA-15) could still be kept even though the content of carboxyl groups was up to 57.2%. Increasing carboxyl content could effectively enhance the loading capacity of Famo. Compared with pure SBA-15, into which Famo could be hardly adsorbed, the largest drug loading capacity of COOH/SBA-15 could achieve 396.9 mg/g. The release of Famo from mesoporous silica was studied in simulated intestine fluid (SIF, pH=7.4). For COOH/SBA-15, the release rate of Famo decreased with narrowing pore size. After grafting TMS groups on the surface of COOH/SBA-15 with hexamethyldisilazane, the release of Famo was greatly delayed with the increasing content of TMS groups.     

Synthesis of double mesoporous core-shell silica spheres with tunable core porosity and their drug release and cancer cell apoptosis properties

In this work, we demonstrate a simple two-pot approach to double mesoporous core–shell silica spheres (DMCSSs) with uniform size of 245–790 nm, shell thickness of 41–80 nm and surface area and total pore volume of 141–618 m² g^?1 and 0.14–0.585 cc g^?1, respectively. First, solid silica spherical particles were synthesized by the Stöber method and used as a core. Second, a mesoporous shell could be formed around the silica cores by using an anionic surfactant and a co-structure directing agent. It was found that mesopores can be anchored within dense silica cores during mesoporous silica shell formation, synchronously the base group with surfactant assistant can etch the dense silica cores to re-organize new mesostructure, so that double mesoporous core–shell silica sphere (DMCSS) structure can be obtained by a single surfactant-templating step. The spherical size and porosity of the silica cores of DMCSS together with shell thickness can be tuned by controlling Stöber parameters, including the concentrations of ammonia, solvent and tetraethoxysilane and the reaction time. DMCSS were loaded with ketoprofen and thymoquinone, which are an anti-inflammatory and a potential novel anti-cancer drug, respectively. Both drugs showed controlled release behavior from the pores of DMCSS. Drug uptakes within DMCSS were ～27 and 81 wt.% for ketoprofen and thymoquinone, respectively. Furthermore, DMCSS loaded with thymoquinone was more effective in inducing cancer cell apoptosis than uncontained thymoquinone, because of the slow release of the drug from the mesoporous structure.     

Synthesis of novel mesoporous silica spheres with starburst pore canal structure

Novel spherical mesoporous silica materials with uniform diameters and starburst mesopore structures were synthesized by a simple one-step procedure with ethanol as the co-solvent in dilute aqueous solution and their formation mechanism was proposed. The arrangement of the pore canal and the diameter of the sphere could be tailored by altering the concentration of ethanol.     

Synthesis and characterization of submicron-sized mesoporous aluminosilicate spheres

Mesoporous aluminosilicate spheres of 0.3–0.4 Μm diameter, with different Si/Al ratios, have been prepared by surfactant templating. Surface area of these materials is in the 510–970 m² g^-1 range and pore diameter in the 15–20 ? range.     

pH-Controllable drug release using hydrogel encapsulated mesoporous silica

Amine-functionalized mesoporous SBA-15 silica loaded with bovine serum albumin (BSA) has been successfully encapsulated with a thin layer coating of poly(acrylic acid) PAA, with the entrapped BSA being released from the PAA-encapsulated SBA-15 at the higher pH value of 7.4 rather than at the lower pH value of 1.2. This novel drug delivery system has a potential application in the release of protein drug to the site of higher pH value, such as small intestine or colon.     

Bioresponsive mesoporous silica nanoparticles for triggered drug release

Mesoporous silica nanoparticles (MSNPs) have garnered a great deal of attention as potential carriers for therapeutic payloads. However, achieving triggered drug release from MSNPs in vivo has been challenging. Here, we describe the synthesis of stimulus-responsive polymer-coated MSNPs and the loading of therapeutics into both the core and shell domains. We characterize MSNP drug-eluting properties in vitro and demonstrate that the polymer-coated MSNPs release doxorubicin in response to proteases present at a tumor site in vivo, resulting in cellular apoptosis. These results demonstrate the utility of polymer-coated nanoparticles in specifically delivering an antitumor payload.     

Synthesis of micron-sized hollow silica spheres with a novel mesoporous shell of MCF

Micron-sized hollow silica spheres whose shells are made up of mesocellular silica foams(MCFs) have been synthesized by one-pot sol-gel method in benzene/water/P123 emulsion.The material is characterized with SEM,TEM,BET and ~(29)Si MAS NMR. The results show that the MCFs of the unique shell of hollow silica spheres were connected by large windows with a narrow distribution of～10 nm in diameter,the inner space of the hollow sphere is accessible.And the formation mechanism of the hollow silica spheres is ...     

Synthesis of photoluminescent carbogenic dots using mesoporous silica spheres as nanoreactors

A novel and facile approach for preparing hydrophilic carbogenic dots (CDs) has been developed with mesoporous silica spheres as nanoreactors by using an impregnation method. The resulting highly efficient photoluminescent CDs without any further treatment are monodisperse, photostable and of low toxicity, and show excellent luminescence properties.     

Spontaneous formation and characterization of silica mesoporous crystal spheres with reverse multiply twinned polyhedral hollows

A crystal is an object with translational symmetry. Basic research into and production of new materials necessitates the preparation of crystals of a particular morphology and with well-defined crystal defects. In this work, we found novel silica mesoporous crystal spheres with polyhedral hollows (icosahedral, such as those observed for proteins of virus capsids, decahedral, Wulff polyhedral, etc.) formed by the reverse multiply twinned bicontinuous double diamond mesostructure. Vesicles with a low-curvature lamellar structure were first formed by the self-assembly of amphiphilic carboxylic acid molecules in the presence of a nonionic surfactant and then underwent a structural transformation process that gave a reverse multiply twinned mesoporous shell while maintaining the hollow shape. These polyhedral hollow crystals showed an enhanced contrast of backscattering signatures relative to the incident acoustic signals and thus could be used as a potential contrast agent in medical ultrasonography with drug loadings in the mesopores.     

Synthesis, characterization and sustaining controlled release effect of mesoporous SBA-15/ramipril composite drug

A loading of ramipril in SBA-15 (Santa Barbara Amorphous) mesoporous material was studied. (SBA-15)-ramipril composite material was characterized by chemical analysis, infrared spectroscopy, powder X-ray diffraction, low temperature N₂ adsorption–desorption at 77 K characterization techniques. Ramipril drug release processes from SBA-15 host to simulated body fluid (SBF), simulated gastric juice (SGJ), simulated intestinal fluid (SIF) were monitored in a simulated way and actions of the sustained release of (SBA-15)-ramipril was studied. The results showed that the loading amount of ramipril drug in SBA-15 was 90.30 mg/g. The cumulative sustained release rate of ramipril composite drug in SBF achieved 99.7 % after 27 h. When the sustained release of composite drug in SGJ was 8 h, the maximum cumulative sustained release ratio achieved 54.9 %. When the sustained release of composite drug was 9 h in SIF, the maximum cumulative sustained release ratio achieved 34.9 %. The method described in this study is suitable for carrying ramipril drug on SBA-15, and a new carrier to load ramipril drug was found. Meanwhile, the efficacy of ramipril drug and time efficacy could be improved.     

Synthesis and characterization of hyperbranched mesoporous silica SBA-15

Branched mesoporous silica SBA-15 materials have been prepared in a simple process using non-ionic surfactant in acidic conditions in the presence of metal ions.     

Synthesis and characterization of colloidal fluorescent mesoporous silica particles

Mesoporous silica particles with narrow size distribution were obtained by a seeded growth process. Depending on the size of seeds and on the time of addition of reactants, the size of particles can be varied between 300 and 1000 nm. In a second step the dye fluorescein isothiocyanate can be embedded. The structure of these new silica particles with low density was investigated by SEM, XRD, BET, and confocal microscopy.     

Synthesis of pH-responsive mesoporous silica nanotubes for controlled release

A novel mesoporous silica tubes (MMT) which possessed pH-sensitive controlled release ability had been fabricated and synthesized by using carbon nanotubes (CNTs) as template. The sample replicated the morphologies of the CNTs successfully. The Brunauer–Emmett–Teller surface area of the materials can reach 1,017 m² g^?1 with the pore size of 3.8 nm. As a model drug, metformin HCl was applied to study the drug loading and control release ability of the materials. MMT possesses higher drug loading ratio (36 %) than that of MCM-41 (27.5 %). The release kinetics were studied in simulated gastric fluid (pH = 1.2) and in simulated proximal intestine fluid (pH = 7. 4), respectively. The result shows that the delivery systems exhibit well pH-sensitive control release ability and the as-synthesized materials have potential application in biomedical field.     

Temperature-sensitive polypeptide brushes-coated mesoporous silica nanoparticles for dual-responsive drug release

A biopolymer-inorganic hybrid system (MSN@PBLGF) is designed and fabricated from mesoporous silica nanoparticles (MSNs) and folic acid (FA)-terminated temperature-sensitive synthetic polypeptide, i.e., poly(γ-benzyl-l-glutamate) (PBLG) derivative, through a thiol-disulfide exchange reaction, where MSNs with high drug loading capacity serve as drug nanocarriers and the biocompatible PBLG biopolymer brushes installed on MSN surface through disulfide bonds endow the system with tumor-specific recognition ability and GSH/temperature dual-stimuli responsiveness. Controlled drug release experiments indicate that DOX can be tightly hosted in the system with limited premature release, but efficiently released in response to an increased concentration of GSH and/or an elevated temperature. Intracellular experiments demonstrate that the DOX-loaded MSN@PBLGF nanohybrid shows outstanding cellular uptake and cell-growth inhibition effects on human lung cancer cell line A549 in comparison with healthy human cells such as hepatocyte cells LO2.     

Temperature-sensitive polypeptide brushes-coated mesoporous silica nanoparticles for dual-responsive drug release

A multifunctional nanohybrid based on mesoporous silica nanoparticle and biocompatible polypeptide was fabricated for targeted and dual-responsive therapy of tumor cells.     

Structure and microstructure of nanoscale mesoporous silica spheres

The addition of alcohol to the synthesis of a mesoporous silica material will induce a transition from hexagonal (MCM-41) to cubic (MCM-48) to a lamellar phase and finally to silica spherical particles (SSP), as the alcohol adopts the role of cosurfactant. This will evolve to a cosolvent function as the alcohol concentration is further increased. X-ray diffraction suggests that a phase regression phenomenon occurs, in contradiction with the g-value. Transmission electron microscopy reveals the structure and the microstructure of the mesoporous silica spherical particles. It is shown that the SSP consists of a core of a truncated octahedron with the MCM-48 cubic structure and radial cylindrical pores grown on the surface of the truncated octahedron. This structure model and a possible formation mechanism are discussed.     

Copolymers with fluorescence properties in mesoporous silica SBA-15:Synthesis and characterization

A novel copolymer with fluorescence properties in mesoporous silica SBA-15 was prepared via a combination of surface-initiated reversible addition-fragmentation chain transfer(RAFT) polymerization and "click" chemistry.A sufficient amount of peroxide groups were introduced into mesoporous silica SBA-15 channel pores and were further used to initiate the RAFT polymerization of styrene and 4-vinylbenzyl azide,resulting in SBA-15 supported polystyrene-co-poly(4-vinylbenzyl azide) copolymer(PS-co-PVBA/SBA-15) hybrid material.The samples were characterized by Fourier transform infrared spectroscopy(FT-IR),transmission electron microscopy(TEM),thermogravimetry analysis(TGA),N_2 adsorption-desorption isotherms and X-ray diffraction(XRD),respectively.The results show that the styrene and 4-vinylbenzyl azide had copolymerized inside mesoporous silica SBA-15.Subsequently,Npropargyl-carbazole(PC) was connected to PS-co-PVBA/SBA-15 hybrid material via "click" reaction,resulting in PS-co-PVBC/SBA-15 with carbazole side groups hybrid material.The fluorescence spectrum is dominated by a broad band from 350 nm to 400 nm in narrow region and the maximum peak is 362 nm,indicating the characteristic absorption of the carbazole group of PS-co-PVBC/SBA-15 hybrid material.     

Synthesis and characterization of organic-inorganic hybrid mesoporous silica materials with new templates

1-Hexadecane-3-methylimidazolium bromide and 1-hexadecane-2,3-dimethylimidazolium bromide were used as new templates for the syntheses of periodic mesoporous organosilica (PMO) materials; using these new templates, ethane-bridged PMO materials were successfully synthesized and characterized under basic conditions.     

Synthesis and characterization of mesoporous silica from selectively acid-treated saponite as the precursors

Mesoporous silicas were synthesized by hydrothermal treatment of selectively acid-treated saponite (an ideal structural formula: Na(1/3)Mg(3)(Si(11/3)Al(1/3))O(10)(OH)(2)), having a 2:1 type layered structure as the silica source and its porous properties were examined and compared with that from kaolinite (an ideal structural formula: Al(2)Si(2)O(5)(OH)(4)), having a 1:1 type layered structure. Synthetic saponite was selectively leached in H(2)SO(4) solutions with various concentrations (0.05-1 M) at 70 degrees C for 0.5 h. The resulting products (precursors) were mixed with cetyltrimethylammonium bromide (CTABr), NaOH and H(2)O, hydrothermally treated at 110 degrees C and removed the CTABr by calcining at 560 degrees C. A hexagonal mesoporous phase was obtained with higher Si/(Al(+Mg)) ratios of the resulting precursors. The XRD patterns of these products show the peaks assigned by a hexagonal lattice with a(0)=4.0-4.6 nm and the crystallinity becomes higher with higher Si/(Al(+Mg)) ratios of the precursors. The specific surface area (S(BET)) values of the present mesoporous silicas range from 800 to 1100 m(2)/g at CTABr/precursor=0.1 and although they are not as high as those from precursors prepared from calcining and acid-treatment of kaolinite (1420 m(2)/g), they are increased to 1400-1500 m(2)/g by increasing the ratio CTABr/precursor 0.2. The reason for the difference in the optimum preparation conditions between saponite and kaolinite may be attributed to the difference in the linkage of the SiO(4) tetrahedra in these precursors (i.e. layered or framework structures), which result in great differences in the selective leaching rates and structures of the resulting silica-rich products.     

Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles

Magnetic mesoporous silica nanoparticles (M-MSNs) are emerging as one of the most appealing candidates for theranostic carriers. Herein, a simple synthesis method of M-MSNs with a single Fe(3)O(4) nanocrystal core and a mesoporous shell with radially aligned pores was elaborated using tetraethyl orthosilicate (TEOS) as silica source, cationic surfactant CTAB as template, and 1,3,5-triisopropylbenzene (TMB)/decane as pore swelling agents. Due to the special localization of TMB during the synthesis process, the pore size was increased with added TMB amount within a limited range, while further employment of TMB lead to severe particle coalescence and not well-developed pore structure. On the other hand, when a proper amount of decane was jointly incorporated with limited amounts of TMB, effective pore expansion of M-MSNs similar to that of analogous mesoporous silica nanoparticles was realized. The resultant M-MSN materials possessed smaller particle size (about 40-70 nm in diameter), tunable pore sizes (3.8-6.1 nm), high surface areas (700-1100 m(2)/g), and large pore volumes (0.44-1.54 cm(3)/g). We also demonstrate their high potential in conventional DNA loading. Maximum loading capacity of salmon sperm DNA (375 mg/g) was obtained by the use of the M-MSN sample with the largest pore size of 6.1 nm.